{
  "@type": "NewsArticle",
  "identifier": "2022--08--16--en--askhn--HackerNews--NewsArticle--32484957",
  "url": "https://news.ycombinator.com/item?id=32484957",
  "headline": "Ask HN: Drug continuation after an RCT ends",
  "publisher": {
    "@type": "Organization",
    "name": "HackerNews",
    "url": "https://news.ycombinator.com",
    "logo": "https://hn.buzzing.cc/avatar.png"
  },
  "description": "Suppose a new treatment is investigated in a Randomized Clinical Trial and the treatment turns out to be a very effective, life changing medication for a particular illness for a participant.  What happens once the RCT ends in terms of continuing access to that particular drug (that was so effective) for particular patients?  Does anyone have insight on ethical/legal obligations for a patient to continue on with the drug? How can a patient continue on the RCT drug once the RCT ends?",
  "keywords": [
    "Ask HN"
  ],
  "genre": "Ask HN",
  "author": {
    "@type": "Person",
    "name": "whathappenswhen",
    "url": "https://news.ycombinator.com/user?id=whathappenswhen"
  },
  "discussionUrl": "https://news.ycombinator.com/item?id=32484957",
  "sameAs": "https://news.ycombinator.com/item?id=32484957",
  "dateCreated": "2022-08-16T16:37:03.816Z",
  "datePublished": "2022-08-16T16:20:48.000Z",
  "dateModified": "2022-08-16T16:37:03.816Z",
  "interactionStatistic": [
    {
      "@type": "InteractionCounter",
      "interactionType": {
        "@type": "LikeAction"
      },
      "userInteractionCount": 1
    },
    {
      "@type": "InteractionCounter",
      "interactionType": {
        "@type": "CommentAction"
      },
      "userInteractionCount": 1
    }
  ],
  "headline_zh-Hans": "Ask HN: RCT结束后继续用药\n",
  "headline_zh-Hant": "Ask HN: RCT結束後繼續用藥\n",
  "@context": [
    "https://schema.org",
    {
      "@vocab": "http://schema.org/",
      "@language": "en",
      "headline_zh-Hans": {
        "@id": "headline",
        "@language": "zh-Hans"
      },
      "headline_zh-Hant": {
        "@id": "headline",
        "@language": "zh-Hant"
      },
      "@version": 1.1,
      "description_zh-Hans": {
        "@id": "description",
        "@language": "zh-Hans"
      },
      "description_zh-Hant": {
        "@id": "description",
        "@language": "zh-Hant"
      }
    }
  ],
  "description_zh-Hans": "假设在随机临床试验中调查了一种新的治疗方法，并且该治疗方法被证明是一种非常有效的、改变参与者特定疾病的药物。 一旦随机临床试验结束，在继续为特定病人提供该特定药物（如此有效）方面会发生什么？ 有人对病人继续用药的道德/法律义务有什么见解吗？一旦RCT结束，病人如何继续使用RCT药物？\n",
  "description_zh-Hant": "假設在隨機臨床試驗中調查了一種新的治療方法，並且該治療方法被證明是一種非常有效的、改變參與者特定疾病的藥物。 一旦隨機臨床試驗結束，在繼續為特定病人提供該特定藥物（如此有效）方面會發生什麼？ 有人對病人繼續用藥的道德/法律義務有什麼見解嗎？一旦RCT結束，病人如何繼續使用RCT藥物？\n"
}